Global Cancer Cachexia Market – Industry Trends and Forecast to 2028

Market Analysis and Insights : Global Cancer Cachexia Market

The cancer cachexia market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of approximately 4.65% in the forecast period of 2021 to 2028. The increasing prevalence of cachexia amongst the geriatric population is escalating the growth of cancer cachexia market.

Cachexia or wasting syndrome refers to a condition of extreme weight loss and fatigue, weakness, muscles atrophy and loss of appetite because of the severe chronic illness. This syndrome is witnessed in the individuals suffering from chronic diseases such as multiple sclerosis, tuberculosis, AIDS, Crohn's disease and others. The pathogenicity of this cancer is known to be multifactorial due to the complex interaction between host and tumor. The cancer is caused by starvation weight loss and excess expenditure of energy by body and anemia.

The growing prevalence of cancer and cancer cachexia and the rise in demand for therapy drugs act as the major factors driving the cancer cachexia market. The rise in number of research and development activities for the discovery of therapeutic drugs and their high demand among consumers and growing technological advancements for the treatment of cancer cachexia accelerate the cancer cachexia market growth. The rise in the investments made in cutting-edge drug research giving birth to new, sophisticated treatments with specific mechanism of action and increase in focus on palliative cancer care influence the cancer cachexia market. Additionally, the growth in population globally, surge in healthcare expenditure and improving healthcare infrastructure and rise in awareness positively affect the cancer cachexia market. Furthermore, the emergence of pipeline products and technological advancement extends profitable opportunity to the cancer cachexia market players in the forecast period of 2021 to 2028.  

On the other hand, the implementation of stringent regulatory requirements and long FDA approval are factors expected to obstruct the cancer cachexia market growth. Lack of awareness regarding the cachexia cancer and concerns regarding the medications are projected to challenge the cancer cachexia market in the forecast period of 2021-2028.

This cancer cachexia market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on cancer cachexia market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Cancer Cachexia Market Scope and Market Size

The cancer cachexia market is segmented on the basis of therapeutics, mechanism of action and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

• On the basis of therapeutics, the cancer cachexia market is segmented into progestogens, corticosteroids, combination therapies and others.
• On the basis of mechanism of action, the cancer cachexia market is segmented into appetite stimulators, weight loss stabilizers and others.
• On the basis of distribution channel, the cancer cachexia market is segmented into hospital stores, retail pharmacy stores and online pharmacy.

Global Cancer Cachexia Market Country Level Analysis

The cancer cachexia market is analyzed and market size insights and trends are provided by country, therapeutics, mechanism of action and distribution channel as referenced above.      

The countries covered in the global cancer cachexia market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the cancer cachexia market because of the presence of a large number of drug manufacturers, advancements in novel technology for the treatment of cancer cachexia, advancing paradigm of care for cancer patients and strong product pipeline for wasting syndrome in the region. Asia-Pacific is expected to witness the highest CAGR in the forecast period of 2021-2028 because of the growing geriatric populations, increasing awareness among people, high prevalence and incidence of the cancer and presence of healthcare professionals for cancer supportive care in the region.

The country section of the cancer cachexia market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The cancer cachexia market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for cancer cachexia market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on cancer cachexia market. The data is available for historic period 2011-2019. 

Competitive Landscape and Cancer Cachexia Market Share Analysis

The cancer cachexia market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to cancer cachexia market.

The major players covered in the cancer cachexia market report are Æterna Zentaris Inc., Alder BioPharmaceuticals Inc., Aphios Corp, Eli Lilly and Co., GTx Inc., Helsinn Group, Merck & Co. Inc., Novartis AG, Bristol-Myers Squibb Co., XBiotech Inc., Marsala Biotech Inc., Inovio Pharmaceuticals, Inc., Astellas Pharma Inc., AstraZeneca PLC, Biotest AG, Boehringer Ingelheim GmbH, Boston Biomedical, InteRNA Technologies B.V., ISU ABXIS Co.,Ltd., AVEO Pharmaceuticals, Inc., Jiangsu Kanion Pharmaceutical Co., Ltd. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-29932